Tim's Wholesale; Denial of Application, 58890-58893 [E7-20443]
Download as PDF
58890
Federal Register / Vol. 72, No. 200 / Wednesday, October 17, 2007 / Notices
amount to the Consent Decree Library at
the stated address.
DEPARTMENT OF JUSTICE
sroberts on PROD1PC70 with NOTICES
Notice of Lodging of Consent Decree
Notice is hereby given that on October
11, 2007, a proposed Consent Decree in
United States v. Maritime Logitics, Inc.,
et al., Civil Action No. C07–5172 JSW
(N.D. Cal.), was lodged with the United
States District Court for the Northern
District of California. The proposed
Consent Decree resolves claims arising
from a January 31, 2005 incident in
which the vessel P/C ALBION sank in
the waters of the Monterey Bay National
Marine Sanctuary and discharged oil.
Under the Consent Decree, the
defendants will pay $1,207,064.00 to the
Coast Guard’s Oil Spill Liability Trust
Fund for costs incurred, and
$392,936.00 to the National Oceanic and
Atmospheric Administration for costs
incurred and for damages. In exchange,
the United States provides a covenant
not to sue for claims pertaining to the
Incident under, inter alia, the Oil
Pollution Act, the Comprehensive
Environmental Response,
Compensation, and Liability Act, and
the National Marine Sanctuaries Act.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the proposed Consent Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and National Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. Maritime Logitics, Inc., et al.,
D.J. Ref. 90–5–1–1–09113.
The proposed Consent Decree may be
examined at the Office of the United
States Attorney, 450 Golden Gate
Avenue, San Francisco, California
94102. During the public comment
period, the Consent Decree may also be
examined on the following Department
of Justice Web site, https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed Consent Decrees may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation no.
(202) 514–1547. In requesting a copy
from the Consent Decree Library, please
enclose a check in the amount of $4.75
(25 cents per page reproduction cost)
payable to the ‘‘U.S. Treasury’’ or, if by
e-mail or fax, forward a check in that
VerDate Aug<31>2005
19:05 Oct 16, 2007
Jkt 214001
Henry S. Friedman,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 07–5125 Filed 10–16–07; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Notice of Lodging of Consent Decree
Under the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA) and Clean Water Act (CWA)
Notice is hereby given that on October
1, 2007, a proposed Consent Decree
(Decree) in United States et al. v. United
States Steel Corp. et al., Civil Action No.
07–CV–4114–JAR was lodged with the
United States District Court for the
District of Kansas.
In this action the United States and
the State of Kansas, in their capacities
as natural resource trustees, sought
recovery from U.S. Steel Corporation
and Citibank Global Holdings for
natural resource damages to the
National Zinc Superfund Site (Site) in
Cherryvale, Kansas and the surrounding
area. The Complaint alleges that
Defendants are liable as successors to
owners or operators of a smelter, which
was previously located and operated at
the Site. The Decree would settle the
government’s claim for injuries to
natural resources at the Site, in return
for a total payment of $495,750,
including $452,750 for restoration
projects and $43,000 for reimbursement
of natural resource damage assessment
costs incurred by the Federal and State
trustees. As specified by the Decree, the
joint recovery for restoration work
would be deposited in the United States
Department of Interior’s Natural
Resource Damage Assessment and
Restoration Fund, and the Federal and
State trustees would make joint
decisions concerning future restoration
expenditures in accordance with a
restoration plan that they would
prepare.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Decree. Comments should
be addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and either e-mailed
to pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States et al. v. United States Steel Corp.
et al., D.J. Ref. 90–11–3–08705.
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
The Decree may be examined at the
Office of the United States Attorney,
1200 Epic Center, 301 N. Main, Wichita,
Kansas 67202. During the public
comment period, the Decree, may also
be examined on the following
Department of Justice Web site, to
https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Decree may also be obtained by mail
from the Consent Decree Library, P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611 or by
faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $6.00 (25 cents per
page reproduction cost) payable to the
U.S. Treasury or, if by e-mail or fax,
forward a check in that amount to the
Consent Decree Library at the stated
address.
Robert E. Maher, Jr.,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 07–5127 Filed 10–16–07; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Tim’s Wholesale; Denial of Application
On March 20, 2006, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Tim’s Wholesale
(Respondent) of Baton Rouge, Louisiana.
The Show Cause Order proposed the
denial of Respondent’s application for a
DEA Certificate of Registration as a
distributor of list I chemicals, on the
ground that granting it a registration
would be ‘‘inconsistent with the public
interest.’’ Show Cause Order at 1.
More specifically, the Show Cause
Order alleged that in December 2004,
Respondent’s President (Mr. Tim Tran)
had applied for a registration to
distribute pseudoephedrine, a list I
chemical which is commonly diverted
into the illicit manufacture of
methamphetamine, a schedule II
controlled substance. Id. at 1–2. The
Show Cause Order alleged that during a
pre-registration investigation, Mr. Tran
stated to DEA Diversion Investigators
(DIs) that his business distributes candy,
snacks, cigarettes and novelties to
‘‘approximately 250 convenience
stores.’’ Id. at 2. The Show Cause Order
further alleged that Mr. Tran stated to
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 72, No. 200 / Wednesday, October 17, 2007 / Notices
sroberts on PROD1PC70 with NOTICES
investigators that ‘‘he was unaware that
traditional cough and cold products
contained pseudoephedrine,’’and that
they ‘‘could be used to make the
controlled substance
methamphetamine.’’ Id.
Next, the Show Cause Order alleged
that after Mr. Tran finally provided a list
of his proposed pseudoephedrine
customers, the DIs conducted customer
verifications. Id. The Show Cause Order
alleged that of the seven customers
contacted by the DIs, six of them stated
that they had no intention of doing
business with Respondent. The Show
Cause Order also alleged that while
Respondent did not have a DEA
registration, the other customer
informed the DIs that it was ‘‘currently
purchasing listed chemical products
from’’ Respondent. Id.
Finally, the Show Cause Order alleged
that Respondent’s proposed customer
base of convenience stores account for
only a very small percentage of the
legitimate commerce in over-the-counter
drug products and that ‘‘convenience
stores continue to be the primary
source’’ of pseudoephedrine which is
diverted into the illicit manufacture of
methamphetamine. Id. at 3. The Show
Cause Order thus concluded that
because Respondent’s management has
‘‘insufficient experience,’’ lacks
‘‘knowledge of the diversion problems
associated with handling listed
chemicals,’’ and had ‘‘distributed listed
chemicals without a registration, it is
unlikely that they would be able to carry
out the responsibilities of a registrant.’’
Id.
The Show Cause Order was served by
certified mail, return receipt requested.
While the return receipt card was not
returned to the Agency, on June 22,
2006, a DEA Diversion Investigator
contacted Respondent’s owner and
confirmed that he had received the
Show Cause Order approximately two
months earlier. I therefore find that
Respondent was properly served.
I further find that because: (1) more
than thirty days have passed since
service of the Show Cause Order, and
(2) neither Respondent, nor anyone
purporting to represent it, has
responded, it has waived its right to a
hearing. See 21 CFR 1309.53(c). I
therefore enter this Decision and Final
Order without a hearing based on
relevant material contained in the
investigative file and make the
following findings.
Findings
On December 15, 2004, Respondent, a
Louisiana corporation, applied for a
DEA Certificate of Registration to
distribute the list I chemical
VerDate Aug<31>2005
19:05 Oct 16, 2007
Jkt 214001
pseudoephedrine. Respondent’s
application was prepared and submitted
by its President, Mr. Tim Tran, and
proposed as its registered location its
facility which is located at 8150 South
Choctaw Drive, Baton Rouge, Louisiana.
Respondent is a wholesale distributor of
cigarettes, candy, snacks, grocery bags,
and novelty items, and has
approximately 250 customers which
include convenience stores and
restaurants in the Baton Rouge area. As
noted in numerous agency orders, such
establishments are not part of the
traditional market for legitimate
consumers of pseudoephedrine
products. See Holloway Distributing, 72
FR 42118, 42119 (2007); D & S Sales, 71
FR 37607, 37608–09 (2006).
Pseudoephedrine is lawfully
marketed under the Food, Drug and
Cosmetic Act as a decongestant. See
Holloway Distributing, 72 FR at 42119.
Because pseudoephedrine is, however,
easily extracted from non-prescription
drug products and used in the illicit
manufacture of methamphetamine, a
schedule II controlled substance, it is
regulated as a list I chemical under the
Controlled Substances Act (CSA). See
21 U.S.C. 802(34); 21 CFR 1308.12(d).
Methamphetamine is a powerful and
addictive central nervous system
stimulant. See Gregg Brothers Wholesale
Co., Inc., 71 FR 59830 (2006). The illegal
manufacture and abuse of
methamphetamine pose a grave threat to
this country. Methamphetamine abuse
has destroyed numerous lives and
families and ravaged communities.
Moreover, because of the toxic nature of
the chemicals used to make the drug, its
manufacture causes serious
environmental harms. Id.
On February 15, 2005, a DEA
Diversion Investigator (DI) telephoned
Mr. Tran to schedule an on-site
inspection of Respondent. During the
conversation, the DI informed Mr. Tran
that he would need to compile a list of
all the customers who would be
purchasing pseudoephedrine products
from his firm, as well as a list of the
pseudoephedrine products that he
intended to sell. According to the DI,
Mr. Tran did not understand that
pseudoephedrine is an active ingredient
in various cold products. Moreover,
during the conversation, Mr. Tran
further stated that he was unaware that
pseudoephedrine was used to
manufacture methamphetamine, a
statement which he repeated during the
on-site inspection.
On February 18, 2005, the above DI
(accompanied by another DI) visited
Respondent at its proposed registered
where they met Mr. Tran. Mr. Tran had
not prepared a list of either his potential
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
58891
customers or a list of the
pseudoephedrine products he intended
to sell. He also stated to investigators
that he would dispose of out-of-date or
damaged pseudoephedrine products in
the garbage and did not know if his
suppliers would take back such
products. Mr. Tran further told
investigators that he was unfamiliar
with the purchase and sale of
pseudoephedrine products. He also told
investigators that he had been in the
wholesale business for approximately
four and a half months.
During the on-site inspection, Mr.
Tran also told investigators that he had
high employee turnover. Moreover, he
did not know the last names of his two
employees, one of whom had been on
the job for a week, the other for two
days. Even though both employees
would have access to pseudoephedrine
products, Mr. Tran stated that he had
not performed background checks on
either of them and did not know how
to do so.
Mr. Tran further stated that he sold to
walk-in customers. When asked how he
would verify whether these customers
were legitimate, Mr. Tran stated that he
knew most of them because he had lived
in Baton Rouge for approximately
twenty years and went to church with
them.
Mr. Tran eventually marked on his
customer list the names of eighteen
stores that he expected would purchase
pseudoephedrine from him. Subsequent
to the on-site inspection, the DIs visited
seven of the establishments. At three of
the stores, the managers told the DIs that
they had never done business with
Respondent; at another, the cashier told
the DIs that the store used a different
supplier. At one store, the manager told
the DIs that while he had used
Respondent in the past, he no longer did
business with it and did not intend to
purchase pseudoephedrine products
from it. At another establishment, the
cashier stated that the store mostly
bought cigarettes from Respondent and
obtained cold products from other
sources. At the final store, the manager
told the DIs that he was currently
purchasing cold products from
Respondent. The record, however, does
not establish what those products were
and whether they contained a list I
chemical.
Discussion
Section 303(h) of the Controlled
Substances Act (CSA) provides that
‘‘[t]he Attorney General shall register an
applicant to distribute a list I chemical
unless the Attorney General determines
that registration of the applicant is
inconsistent with the public interest.’’
E:\FR\FM\17OCN1.SGM
17OCN1
58892
Federal Register / Vol. 72, No. 200 / Wednesday, October 17, 2007 / Notices
21 U.S.C. 823(h). In making this
determination, Congress directed that I
consider the following factors:
(1) maintenance by the applicant of
effective controls against diversion of listed
chemicals into other than legitimate
channels;
(2) compliance by the applicant with
applicable Federal, State, and local law;
(3) any prior conviction record of the
applicant under Federal or State laws relating
to controlled substances or to chemicals
controlled under Federal or State law;
(4) any past experience of the applicant in
the manufacture and distribution of
chemicals; and
(5) such other factors as are relevant to and
consistent with the public health and safety.
Id. § 823(h).
‘‘These factors are considered in the
disjunctive.’’ Joy’s Ideas, 70 FR 33195,
33197 (2005). I may rely on any one or
a combination of factors, and may give
each factor the weight I deem
appropriate in determining whether an
application for a registration should be
denied. See, e.g., David M. Starr, 71 FR
39367, 39368 (2006); Energy Outlet, 64
FR 14269 (1999). Moreover, I am ‘‘not
required to make findings as to all of the
factors.’’ Hoxie v. DEA, 419 F.3d 477,
482 (6th Cir. 2005); Morall v. DEA, 412
F.3d 165, 173–74 (D.C. Cir. 2005). In
this case, I conclude that Factors One,
Four, and Five establish that granting
Respondent a registration would be
‘‘inconsistent with the public interest.’’
21 U.S.C. 823(h). Respondent’s
application will therefore be denied.
sroberts on PROD1PC70 with NOTICES
Factor One—The Maintenance of
Effective Controls Against Diversion
In several respects, the investigative
file establishes that Respondent would
not maintain effective controls against
diversion. First, the file establishes that
Respondent intends to dispose of out-ofdate or damaged pseudoephedrine
products by throwing them in its trash.
This is not a proper method of disposing
of list I chemical products, which can
still be used to manufacture
methamphetamine even if they are outof-date or damaged.
Second, Respondent told the DIs that
he did not conduct background checks
on his employees and, indeed, he did
not even know their last names. Under
DEA’s regulations, a ‘‘registrant shall
exercise caution in the consideration of
employment of persons who will have
access to listed chemicals, who have
been convicted of a felony offense
relating to controlled substances or
listed chemicals, or who have, at any
time, had an application for registration
with DEA denied, had a DEA
registration revoked, or surrendered a
DEA registration for cause.’’ 21 CFR
VerDate Aug<31>2005
19:05 Oct 16, 2007
Jkt 214001
1309.72(a). Moreover, a ‘‘registrant
should be aware of the circumstances
regarding the action against the
potential employee and the
rehabilitative efforts following the
action,’’ and a ‘‘registrant shall assess
the risks involved in employing such
persons.’’ Id. Conducting a background
check on a potential employee is
therefore essential to comply with the
regulation and to make an accurate
assessment of the risk posed by the
person’s employment.
Finally, Respondent’s proposed
method of determining the legitimacy of
his walk-in customers is obviously
inadequate. Mr. Tran stated that he
knew most of his customers because he
had lived in Baton Rouge, a city of
sizable population, for twenty years,
and went to church with them. Mr. Tran
offered no explanation as to how he
would verify the legitimacy of those
walk-in customers he did not personally
know.
Each of the above reasons provides an
independent basis to conclude that
Respondent would not maintain
effective controls against diversion.
Moreover, this finding provides reason
alone to conclude that granting
Respondent’s application would be
‘‘inconsistent with the public interest.’’
21 U.S.C. 823(h).
Factor Four and Five—The Applicant’s
Experience in Distributing List I
Chemicals and Other Factors Relevant
to and Consistent With Public Health
and Safety
As I have previously held, ‘‘an
applicant’s lack of experience in
distributing list I chemicals creates a
greater risk of diversion and thus weigh
heavily against the granting of an
application.’’ Planet Trading, Inc., 72 FR
11055, 11057 (2007) (quoting Tri-County
Bait Distributors, 71 FR 52160, 52163
(2006)). Moreover, ‘‘[d]istributors of list
I chemicals are subject to a
comprehensive and complex regulatory
scheme.’’ Id. at 11058 (citing 21 CFR
Pts. 1309 & 1310).
Here, Mr. Tran has no experience in
the distribution of list I chemicals and
the fulfillment of the regulatory
obligations imposed by the CSA. See id.
Moreover, Mr. Tran did not understand
that pseudoephedrine is the active
ingredient in various cold products and
was unfamiliar with the problem caused
by the diversion of the chemical into the
illicit manufacture of
methamphetamine. See id. (rejecting
application based on applicant’s lack of
product knowledge). Mr. Tran’s lack of
experience and knowledge does not
bode well for his performance as a
registrant who will prevent diversion.
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Numerous DEA orders establish that
the sale of list I chemical products by
non-traditional retailers is an area of
particular concern in preventing
diversion of these products into the
illicit manufacture of
methamphetamine. See, e.g., Joey
Enterprises, 70 FR 76866, 76867 (2005).
As Joey Enterprises explains, ‘‘[w]hile
there are no specific prohibitions under
the Controlled Substances Act regarding
the sale of listed chemical products to
[gas stations and convenience stores],
DEA has nevertheless found that [these
entities] constitute sources for the
diversion of listed chemical products.’’
Id. See also Rick’s Picks, 72 FR 18279
(2007) (noting role of non-traditional
retailers such as convenience stores and
gas stations in supplying meth. cooks);
TNT Distributors, 70 FR 12729, 12730
(2005) (special agent testified that ‘‘80 to
90 percent of ephedrine and
pseudoephedrine being used [in
Tennessee] to manufacture
methamphetamine was being obtained
from convenience stores’’); OTC
Distribution Co., 68 FR 70538, 70541
(2003) (noting ‘‘over 20 different
seizures of [non-traditional market
distributor’s] pseudoephedrine product
at clandestine sites,’’ and that in eightmonth period, distributor’s product
‘‘was seized at clandestine laboratories
in eight states, with over 2 million
dosage units seized in Oklahoma
alone.’’); MDI Pharmaceuticals, 68 FR
4233, 4236 (2003) (finding that
‘‘pseudoephedrine products distributed
by [gray market distributor] have been
uncovered at numerous clandestine
methamphetamine settings throughout
the United States and/or discovered in
the possession of individuals apparently
involved in the illicit manufacture of
methamphetamine’’).
DEA orders have thus found that there
is a substantial risk of diversion of List
I chemicals into the illicit manufacture
of methamphetamine when these
products are sold by non-traditional
retailers. See, e.g., Joy’s Ideas, 70 FR at
33199 (finding that the risk of diversion
was ‘‘real’’ and ‘‘substantial’’); Jay
Enterprises, 70 FR at 24621 (noting
‘‘heightened risk of diversion’’ should
application be granted). Under DEA
precedents, an applicant’s proposal to
sell into the non-traditional market
weighs heavily against the granting of a
registration under factor five. So too
here.
Because of the methamphetamine
epidemic’s devastating impact on
communities and families throughout
the country, DEA has repeatedly denied
an application when an applicant
proposed to sell into the non-traditional
market and the analysis of one of the
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 72, No. 200 / Wednesday, October 17, 2007 / Notices
other statutory factors supports the
conclusion that granting the application
would create an unacceptable risk of
diversion. Thus, in Xtreme Enterprises,
67 FR 76195, 76197 (2002), my
predecessor denied an application
observing that the respondent’s ‘‘lack of
a criminal record, compliance with the
law and willingness to upgrade her
security system are far outweighed by
her lack of experience with selling List
I chemicals and the fact that she intends
to sell ephedrine almost exclusively in
the gray market.’’ More recently, I
denied an application observing that the
respondent’s ‘‘lack of a criminal record
and any intent to comply with the law
and regulations are far outweighed by
his lack of experience and the
company’s intent to sell ephedrine and
pseudoephedrine exclusively to the gray
market.’’ Jay Enterprises, 70 FR at
24621. Accord Planet Trading, 72 FR at
11058; Prachi Enterprises, 69 FR 69407,
69409 (2004).
Here, the investigative file supports
additional adverse findings beyond
those which DEA has repeatedly held
are sufficient to warrant the denial of an
application to distribute list I chemicals.
Respondent clearly lacks effective
controls against diversion, has no
experience in the licit wholesale
distribution of List I chemical products,
and yet intends to distribute these
products to non-traditional retailers, a
market in which the risk of diversion is
substantial. See Planet Trading, 72 FR at
11058; Taby Enterprises of Osceola,
Inc., 71 FR 71557, 71559 (2006). Given
these findings,1 it is indisputable that
granting Respondent’s application
would be ‘‘inconsistent with the public
interest.’’ 21 U.S.C. 823(h).
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(h), as well as 28 CFR
0.100(b) & 0.104, I order that the
application of Tim’s Wholesale, for a
DEA Certificate of Registration as a
distributor of list I chemicals be, and it
hereby is, denied. This order is effective
November 16, 2007.
sroberts on PROD1PC70 with NOTICES
Dated: October 9, 2007.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E7–20443 Filed 10–16–07; 8:45 am]
BILLING CODE 4410–09–P
1 Because these findings establish that granting
Respondent’s application would create an
unacceptable risk of diversion, it is unnecessary to
make any findings on the remaining factors.
VerDate Aug<31>2005
19:05 Oct 16, 2007
Jkt 214001
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0114]
Office for Victims of Crime; Agency
Information Collection Activities:
Proposed Collection; Comments
Requested
30-Day Notice of Information
Collection Under Review; Extension of
a Currently Approved Collection;
Victims of Crime Act, Victim
Compensation Grant Program, State
Performance Report.
ACTION:
The Department of Justice (DOJ),
Office for Victims of Crime (OVC), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register, Volume 72, Number 155, page
45270–45271 on month, day, year,
allowing for a 60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until November 16, 2007. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to The Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
58893
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Victims of Crime Act, Victim
Compensation Grant Program, State
Performance Report.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form Number: OJP ADMIN FORM
7390/6. Office for Victims of Crime,
Office of Justice Programs, Department
of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State Government.
The form is used by State Government
to submit Annual Performance Report
data about claims for victim
compensation.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 53
respondents will complete the form
within 2 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 106
total annual burden hours associated
with this collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: October 11, 2007.
Lynn Bryant,
Department Clearance Officer, PRA,
Department of Justice.
[FR Doc. E7–20456 Filed 10–16–07; 8:45 am]
BILLING CODE 4410–18–P
E:\FR\FM\17OCN1.SGM
17OCN1
Agencies
[Federal Register Volume 72, Number 200 (Wednesday, October 17, 2007)]
[Notices]
[Pages 58890-58893]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20443]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Tim's Wholesale; Denial of Application
On March 20, 2006, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, issued an Order to
Show Cause to Tim's Wholesale (Respondent) of Baton Rouge, Louisiana.
The Show Cause Order proposed the denial of Respondent's application
for a DEA Certificate of Registration as a distributor of list I
chemicals, on the ground that granting it a registration would be
``inconsistent with the public interest.'' Show Cause Order at 1.
More specifically, the Show Cause Order alleged that in December
2004, Respondent's President (Mr. Tim Tran) had applied for a
registration to distribute pseudoephedrine, a list I chemical which is
commonly diverted into the illicit manufacture of methamphetamine, a
schedule II controlled substance. Id. at 1-2. The Show Cause Order
alleged that during a pre-registration investigation, Mr. Tran stated
to DEA Diversion Investigators (DIs) that his business distributes
candy, snacks, cigarettes and novelties to ``approximately 250
convenience stores.'' Id. at 2. The Show Cause Order further alleged
that Mr. Tran stated to
[[Page 58891]]
investigators that ``he was unaware that traditional cough and cold
products contained pseudoephedrine,''and that they ``could be used to
make the controlled substance methamphetamine.'' Id.
Next, the Show Cause Order alleged that after Mr. Tran finally
provided a list of his proposed pseudoephedrine customers, the DIs
conducted customer verifications. Id. The Show Cause Order alleged that
of the seven customers contacted by the DIs, six of them stated that
they had no intention of doing business with Respondent. The Show Cause
Order also alleged that while Respondent did not have a DEA
registration, the other customer informed the DIs that it was
``currently purchasing listed chemical products from'' Respondent. Id.
Finally, the Show Cause Order alleged that Respondent's proposed
customer base of convenience stores account for only a very small
percentage of the legitimate commerce in over-the-counter drug products
and that ``convenience stores continue to be the primary source'' of
pseudoephedrine which is diverted into the illicit manufacture of
methamphetamine. Id. at 3. The Show Cause Order thus concluded that
because Respondent's management has ``insufficient experience,'' lacks
``knowledge of the diversion problems associated with handling listed
chemicals,'' and had ``distributed listed chemicals without a
registration, it is unlikely that they would be able to carry out the
responsibilities of a registrant.'' Id.
The Show Cause Order was served by certified mail, return receipt
requested. While the return receipt card was not returned to the
Agency, on June 22, 2006, a DEA Diversion Investigator contacted
Respondent's owner and confirmed that he had received the Show Cause
Order approximately two months earlier. I therefore find that
Respondent was properly served.
I further find that because: (1) more than thirty days have passed
since service of the Show Cause Order, and (2) neither Respondent, nor
anyone purporting to represent it, has responded, it has waived its
right to a hearing. See 21 CFR 1309.53(c). I therefore enter this
Decision and Final Order without a hearing based on relevant material
contained in the investigative file and make the following findings.
Findings
On December 15, 2004, Respondent, a Louisiana corporation, applied
for a DEA Certificate of Registration to distribute the list I chemical
pseudoephedrine. Respondent's application was prepared and submitted by
its President, Mr. Tim Tran, and proposed as its registered location
its facility which is located at 8150 South Choctaw Drive, Baton Rouge,
Louisiana. Respondent is a wholesale distributor of cigarettes, candy,
snacks, grocery bags, and novelty items, and has approximately 250
customers which include convenience stores and restaurants in the Baton
Rouge area. As noted in numerous agency orders, such establishments are
not part of the traditional market for legitimate consumers of
pseudoephedrine products. See Holloway Distributing, 72 FR 42118, 42119
(2007); D & S Sales, 71 FR 37607, 37608-09 (2006).
Pseudoephedrine is lawfully marketed under the Food, Drug and
Cosmetic Act as a decongestant. See Holloway Distributing, 72 FR at
42119. Because pseudoephedrine is, however, easily extracted from non-
prescription drug products and used in the illicit manufacture of
methamphetamine, a schedule II controlled substance, it is regulated as
a list I chemical under the Controlled Substances Act (CSA). See 21
U.S.C. 802(34); 21 CFR 1308.12(d).
Methamphetamine is a powerful and addictive central nervous system
stimulant. See Gregg Brothers Wholesale Co., Inc., 71 FR 59830 (2006).
The illegal manufacture and abuse of methamphetamine pose a grave
threat to this country. Methamphetamine abuse has destroyed numerous
lives and families and ravaged communities. Moreover, because of the
toxic nature of the chemicals used to make the drug, its manufacture
causes serious environmental harms. Id.
On February 15, 2005, a DEA Diversion Investigator (DI) telephoned
Mr. Tran to schedule an on-site inspection of Respondent. During the
conversation, the DI informed Mr. Tran that he would need to compile a
list of all the customers who would be purchasing pseudoephedrine
products from his firm, as well as a list of the pseudoephedrine
products that he intended to sell. According to the DI, Mr. Tran did
not understand that pseudoephedrine is an active ingredient in various
cold products. Moreover, during the conversation, Mr. Tran further
stated that he was unaware that pseudoephedrine was used to manufacture
methamphetamine, a statement which he repeated during the on-site
inspection.
On February 18, 2005, the above DI (accompanied by another DI)
visited Respondent at its proposed registered where they met Mr. Tran.
Mr. Tran had not prepared a list of either his potential customers or a
list of the pseudoephedrine products he intended to sell. He also
stated to investigators that he would dispose of out-of-date or damaged
pseudoephedrine products in the garbage and did not know if his
suppliers would take back such products. Mr. Tran further told
investigators that he was unfamiliar with the purchase and sale of
pseudoephedrine products. He also told investigators that he had been
in the wholesale business for approximately four and a half months.
During the on-site inspection, Mr. Tran also told investigators
that he had high employee turnover. Moreover, he did not know the last
names of his two employees, one of whom had been on the job for a week,
the other for two days. Even though both employees would have access to
pseudoephedrine products, Mr. Tran stated that he had not performed
background checks on either of them and did not know how to do so.
Mr. Tran further stated that he sold to walk-in customers. When
asked how he would verify whether these customers were legitimate, Mr.
Tran stated that he knew most of them because he had lived in Baton
Rouge for approximately twenty years and went to church with them.
Mr. Tran eventually marked on his customer list the names of
eighteen stores that he expected would purchase pseudoephedrine from
him. Subsequent to the on-site inspection, the DIs visited seven of the
establishments. At three of the stores, the managers told the DIs that
they had never done business with Respondent; at another, the cashier
told the DIs that the store used a different supplier. At one store,
the manager told the DIs that while he had used Respondent in the past,
he no longer did business with it and did not intend to purchase
pseudoephedrine products from it. At another establishment, the cashier
stated that the store mostly bought cigarettes from Respondent and
obtained cold products from other sources. At the final store, the
manager told the DIs that he was currently purchasing cold products
from Respondent. The record, however, does not establish what those
products were and whether they contained a list I chemical.
Discussion
Section 303(h) of the Controlled Substances Act (CSA) provides that
``[t]he Attorney General shall register an applicant to distribute a
list I chemical unless the Attorney General determines that
registration of the applicant is inconsistent with the public
interest.''
[[Page 58892]]
21 U.S.C. 823(h). In making this determination, Congress directed that
I consider the following factors:
(1) maintenance by the applicant of effective controls against
diversion of listed chemicals into other than legitimate channels;
(2) compliance by the applicant with applicable Federal, State,
and local law;
(3) any prior conviction record of the applicant under Federal
or State laws relating to controlled substances or to chemicals
controlled under Federal or State law;
(4) any past experience of the applicant in the manufacture and
distribution of chemicals; and
(5) such other factors as are relevant to and consistent with
the public health and safety.
Id. Sec. 823(h).
``These factors are considered in the disjunctive.'' Joy's Ideas,
70 FR 33195, 33197 (2005). I may rely on any one or a combination of
factors, and may give each factor the weight I deem appropriate in
determining whether an application for a registration should be denied.
See, e.g., David M. Starr, 71 FR 39367, 39368 (2006); Energy Outlet, 64
FR 14269 (1999). Moreover, I am ``not required to make findings as to
all of the factors.'' Hoxie v. DEA, 419 F.3d 477, 482 (6th Cir. 2005);
Morall v. DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005). In this case, I
conclude that Factors One, Four, and Five establish that granting
Respondent a registration would be ``inconsistent with the public
interest.'' 21 U.S.C. 823(h). Respondent's application will therefore
be denied.
Factor One--The Maintenance of Effective Controls Against Diversion
In several respects, the investigative file establishes that
Respondent would not maintain effective controls against diversion.
First, the file establishes that Respondent intends to dispose of out-
of-date or damaged pseudoephedrine products by throwing them in its
trash. This is not a proper method of disposing of list I chemical
products, which can still be used to manufacture methamphetamine even
if they are out-of-date or damaged.
Second, Respondent told the DIs that he did not conduct background
checks on his employees and, indeed, he did not even know their last
names. Under DEA's regulations, a ``registrant shall exercise caution
in the consideration of employment of persons who will have access to
listed chemicals, who have been convicted of a felony offense relating
to controlled substances or listed chemicals, or who have, at any time,
had an application for registration with DEA denied, had a DEA
registration revoked, or surrendered a DEA registration for cause.'' 21
CFR 1309.72(a). Moreover, a ``registrant should be aware of the
circumstances regarding the action against the potential employee and
the rehabilitative efforts following the action,'' and a ``registrant
shall assess the risks involved in employing such persons.'' Id.
Conducting a background check on a potential employee is therefore
essential to comply with the regulation and to make an accurate
assessment of the risk posed by the person's employment.
Finally, Respondent's proposed method of determining the legitimacy
of his walk-in customers is obviously inadequate. Mr. Tran stated that
he knew most of his customers because he had lived in Baton Rouge, a
city of sizable population, for twenty years, and went to church with
them. Mr. Tran offered no explanation as to how he would verify the
legitimacy of those walk-in customers he did not personally know.
Each of the above reasons provides an independent basis to conclude
that Respondent would not maintain effective controls against
diversion. Moreover, this finding provides reason alone to conclude
that granting Respondent's application would be ``inconsistent with the
public interest.'' 21 U.S.C. 823(h).
Factor Four and Five--The Applicant's Experience in Distributing List I
Chemicals and Other Factors Relevant to and Consistent With Public
Health and Safety
As I have previously held, ``an applicant's lack of experience in
distributing list I chemicals creates a greater risk of diversion and
thus weigh heavily against the granting of an application.'' Planet
Trading, Inc., 72 FR 11055, 11057 (2007) (quoting Tri-County Bait
Distributors, 71 FR 52160, 52163 (2006)). Moreover, ``[d]istributors of
list I chemicals are subject to a comprehensive and complex regulatory
scheme.'' Id. at 11058 (citing 21 CFR Pts. 1309 & 1310).
Here, Mr. Tran has no experience in the distribution of list I
chemicals and the fulfillment of the regulatory obligations imposed by
the CSA. See id. Moreover, Mr. Tran did not understand that
pseudoephedrine is the active ingredient in various cold products and
was unfamiliar with the problem caused by the diversion of the chemical
into the illicit manufacture of methamphetamine. See id. (rejecting
application based on applicant's lack of product knowledge). Mr. Tran's
lack of experience and knowledge does not bode well for his performance
as a registrant who will prevent diversion.
Numerous DEA orders establish that the sale of list I chemical
products by non-traditional retailers is an area of particular concern
in preventing diversion of these products into the illicit manufacture
of methamphetamine. See, e.g., Joey Enterprises, 70 FR 76866, 76867
(2005). As Joey Enterprises explains, ``[w]hile there are no specific
prohibitions under the Controlled Substances Act regarding the sale of
listed chemical products to [gas stations and convenience stores], DEA
has nevertheless found that [these entities] constitute sources for the
diversion of listed chemical products.'' Id. See also Rick's Picks, 72
FR 18279 (2007) (noting role of non-traditional retailers such as
convenience stores and gas stations in supplying meth. cooks); TNT
Distributors, 70 FR 12729, 12730 (2005) (special agent testified that
``80 to 90 percent of ephedrine and pseudoephedrine being used [in
Tennessee] to manufacture methamphetamine was being obtained from
convenience stores''); OTC Distribution Co., 68 FR 70538, 70541 (2003)
(noting ``over 20 different seizures of [non-traditional market
distributor's] pseudoephedrine product at clandestine sites,'' and that
in eight-month period, distributor's product ``was seized at
clandestine laboratories in eight states, with over 2 million dosage
units seized in Oklahoma alone.''); MDI Pharmaceuticals, 68 FR 4233,
4236 (2003) (finding that ``pseudoephedrine products distributed by
[gray market distributor] have been uncovered at numerous clandestine
methamphetamine settings throughout the United States and/or discovered
in the possession of individuals apparently involved in the illicit
manufacture of methamphetamine'').
DEA orders have thus found that there is a substantial risk of
diversion of List I chemicals into the illicit manufacture of
methamphetamine when these products are sold by non-traditional
retailers. See, e.g., Joy's Ideas, 70 FR at 33199 (finding that the
risk of diversion was ``real'' and ``substantial''); Jay Enterprises,
70 FR at 24621 (noting ``heightened risk of diversion'' should
application be granted). Under DEA precedents, an applicant's proposal
to sell into the non-traditional market weighs heavily against the
granting of a registration under factor five. So too here.
Because of the methamphetamine epidemic's devastating impact on
communities and families throughout the country, DEA has repeatedly
denied an application when an applicant proposed to sell into the non-
traditional market and the analysis of one of the
[[Page 58893]]
other statutory factors supports the conclusion that granting the
application would create an unacceptable risk of diversion. Thus, in
Xtreme Enterprises, 67 FR 76195, 76197 (2002), my predecessor denied an
application observing that the respondent's ``lack of a criminal
record, compliance with the law and willingness to upgrade her security
system are far outweighed by her lack of experience with selling List I
chemicals and the fact that she intends to sell ephedrine almost
exclusively in the gray market.'' More recently, I denied an
application observing that the respondent's ``lack of a criminal record
and any intent to comply with the law and regulations are far
outweighed by his lack of experience and the company's intent to sell
ephedrine and pseudoephedrine exclusively to the gray market.'' Jay
Enterprises, 70 FR at 24621. Accord Planet Trading, 72 FR at 11058;
Prachi Enterprises, 69 FR 69407, 69409 (2004).
Here, the investigative file supports additional adverse findings
beyond those which DEA has repeatedly held are sufficient to warrant
the denial of an application to distribute list I chemicals. Respondent
clearly lacks effective controls against diversion, has no experience
in the licit wholesale distribution of List I chemical products, and
yet intends to distribute these products to non-traditional retailers,
a market in which the risk of diversion is substantial. See Planet
Trading, 72 FR at 11058; Taby Enterprises of Osceola, Inc., 71 FR
71557, 71559 (2006). Given these findings,\1\ it is indisputable that
granting Respondent's application would be ``inconsistent with the
public interest.'' 21 U.S.C. 823(h).
---------------------------------------------------------------------------
\1\ Because these findings establish that granting Respondent's
application would create an unacceptable risk of diversion, it is
unnecessary to make any findings on the remaining factors.
---------------------------------------------------------------------------
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(h), as well
as 28 CFR 0.100(b) & 0.104, I order that the application of Tim's
Wholesale, for a DEA Certificate of Registration as a distributor of
list I chemicals be, and it hereby is, denied. This order is effective
November 16, 2007.
Dated: October 9, 2007.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E7-20443 Filed 10-16-07; 8:45 am]
BILLING CODE 4410-09-P